Anja Davis Norbye1,2,3, Rune Midgard2,4, Gyrd Thrane5. 1. Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway. 2. Department of Neurology, Molde Hospital, Møre and Romsdal Health Trust, Molde, Norway. 3. Department of Physiotherapy, University Hospital of North Norway, Tromsø, Norway. 4. Unit for Applied Clinical Research, Norwegian University of Science and Technology, Trondheim, Norway. 5. Department of Health and Care Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
Abstract
OBJECTIVE: More than 80% of people with multiple sclerosis (MS) are affected by spasticity. Spasticity is known to reduce quality of life and contribute to additional symptoms, such as pain and reduced mobility, but the association between spasticity, balance, and mobility has not yet been established. Our aim was to examine whether a relationship exists between spasticity in the lower limbs, balance, and gait, as well as to explore the involvement of different muscle groups. METHODS: This study employed a cross-sectional design. Thirty patients with MS were included. The Modified Ashworth Scale (MAS) was used to examine spasticity in the ankle plantar flexors, knee extensors, and hip adductors. Balance was measured using the Mini-Balance Evaluation Systems Test, and gait with the 2-Minute Walk Test. The participants were tested once with no additional follow-up. Spearman's correlation, recursive partitioning, and linear regression analyses were used to explore the association. RESULTS: A significant correlation between gait distance and spasticity in the ankle plantar flexors (ρ = -.69, p < .001) and knee extensors (ρ = -.45, p = .012) was observed. Balance significantly correlated with spasticity in ankle plantar flexors (ρ = -.69, p < .001), knee extensors (ρ = -.52, p = .003), and hip adductors (ρ = -.5, p = .005). The relationship between spasticity in ankle plantar flexors and hip adductors was significant, even from low levels of spasticity, whereas MAS score ≥ 2 was clinically correlated with a decrease in gait and balance function. Adjustments for sex, age, or years since diagnosis had only minor impact on the results. CONCLUSIONS: This study indicates that spasticity in the lower limbs is clinically significantly associated with mobility in people with MS.
OBJECTIVE: More than 80% of people with multiple sclerosis (MS) are affected by spasticity. Spasticity is known to reduce quality of life and contribute to additional symptoms, such as pain and reduced mobility, but the association between spasticity, balance, and mobility has not yet been established. Our aim was to examine whether a relationship exists between spasticity in the lower limbs, balance, and gait, as well as to explore the involvement of different muscle groups. METHODS: This study employed a cross-sectional design. Thirty patients with MS were included. The Modified Ashworth Scale (MAS) was used to examine spasticity in the ankle plantar flexors, knee extensors, and hip adductors. Balance was measured using the Mini-Balance Evaluation Systems Test, and gait with the 2-Minute Walk Test. The participants were tested once with no additional follow-up. Spearman's correlation, recursive partitioning, and linear regression analyses were used to explore the association. RESULTS: A significant correlation between gait distance and spasticity in the ankle plantar flexors (ρ = -.69, p < .001) and knee extensors (ρ = -.45, p = .012) was observed. Balance significantly correlated with spasticity in ankle plantar flexors (ρ = -.69, p < .001), knee extensors (ρ = -.52, p = .003), and hip adductors (ρ = -.5, p = .005). The relationship between spasticity in ankle plantar flexors and hip adductors was significant, even from low levels of spasticity, whereas MAS score ≥ 2 was clinically correlated with a decrease in gait and balance function. Adjustments for sex, age, or years since diagnosis had only minor impact on the results. CONCLUSIONS: This study indicates that spasticity in the lower limbs is clinically significantly associated with mobility in people with MS.
Authors: Bobbette J Miller; Thubi Ha Kolobe; Rebecca D Larson; Brian A Pribble; Gabriel Pardo; Shirley A James Journal: Mult Scler J Exp Transl Clin Date: 2022-01-05
Authors: Luis Andreu-Caravaca; Domingo J Ramos-Campo; Linda H Chung; Pedro Manonelles; Oriol Abellán-Aynés; Jacobo Á Rubio-Arias Journal: Biomed Res Int Date: 2021-10-21 Impact factor: 3.411
Authors: Elke Warmerdam; Maike Schumacher; Thorben Beyer; Patrik Theodor Nerdal; Linda Schebesta; Klarissa H Stürner; Kirsten E Zeuner; Clint Hansen; Walter Maetzler Journal: Front Neurol Date: 2022-03-29 Impact factor: 4.003
Authors: Pedro Moreno-Navarro; Ramón Gomez-Illán; Carmen Carpena-Juan; Ángel P Sempere; Francisco J Vera-Garcia; David Barbado Journal: J Clin Med Date: 2020-05-08 Impact factor: 4.241